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Abstract – 2-Selenoxo-1,3-thiazolidin-4-ones (selenorhodanines) (7a-h) 
and 2-selenoxo-1,3-thiazinanes (8a-c) can easily be synthesized in a one-
pot procedure from aryl isoselenocyanates and α- and β-mercapto 
carboxylic acids, respectively. 
 
 
INTRODUCTION 
 
During the last 25 years, organoselenium chemistry underwent a spectacular mutation: from an 
exotic area of science, practised by a few specialists, it became a relatively well-mastered 
methodology widely used by organic chemists. The key to this success is that a fair number of 
selenium based reagents and reactions have been discovered, which allow specific 
transformations to be performed selectively and often under mild conditions. The interest in 
selenium-containing compounds has increased not only because of their remarkable reactivities 
and chemical properties2–8 but also because of their pharmaceutical applications.9–16 
Organoselenium compounds are now an important class of biologically active products.17,18 
Shamberger15 widely evidenced the importance of selenium in biology, in human health,19 in 
cancer chemoprevention,20 in food,21–23 and in plants.24,25 
 
Many syntheses of selenium-containing heterocycles involve the use of toxic selenium 
reagents, which are often difficult to handle and to store. On the other hand, isoselenocyanates 
are very useful starting materials26 since they are easy to prepare27 and are relatively stable. 
 We have shown that they are the reagents of choice for the preparation of selenium-containing 
heterocycles such as 1,3-selenazole[5,4-b]pyridines,28 selenet-2(2H)-imines,29 1,3-selen-
azoles,30,31 imidazole diselenides,32 6H-[5,1,3]benzoselenadiazocines,33 and 1,2,3-selena-
diazoles.34 
 
Rhodanine derivatives (2-thioxo-1,3-thiazolidin-4-ones) have been extensively investigated. 
They exhibit various biological activities,35 e.g., antidiabetic,36 antibacterial, fungicidal, 
antiparasitic, and antituberculous.37,38 On the other hand, there were no reports on the 
synthesis of 2-selenorhodanine derivatives until the recent work of Tejchman and Korohoda.39 
As in several other reports, the C=Se bond was introduced by the use of highly toxic hydrogen 
selenide. The key step of this method is the substitution of a MeS group or a R(Me)N group by 
HSe in various derivatives of imidazolidine,40a 1,3-thiazolidine,40b 1,3-thiazoline,40c,41 and 
pyridine.42 
 
Recently, we have described the synthesis of 2-imino-1,3-selenazolidines (3, n = 2),43 2-imino-
1,3-selenazinanes (3, n = 3),43 and 1,3-selenazolidin-4-ones (5)44 from isoselenocyanates by 
the nucleophilic attack of a primary amine and a carbon nucleophile, respectively (Scheme 1). 
To the best of our knowledge, only a few articles concerning the nucleophilic attack of a thiol on 
isothiocyanates have been published45–50 and even less involving isoselenocyanates.51,52  For 
this reason, we investigated the reactions of mercapto carboxylic acids with isoselenocyanates 
with the aim of preparing selenaheterocycles by a subsequent cyclization of the initially formed 
adducts. 
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 RESULTS AND DISCUSSION 
 
The reactions of aryl isoselenocyanates (1a-e) with equimolar amounts of 2-mercaptoacetic 
acid (6a) in a mixture of ethanol and water occurred already at room temperature. Typically, the 
reactions were completed after 3–4 h (TLC control). After aqueous workup and recrystallization 
of the precipitate from EtOH, 2-selenoxo-1,3-thiazolidin-4-ones (7a-e), i.e., selenorhodanines, 
were obtained as orange crystals in good to excellent yields (Scheme 2, Table 1). In the NMR 
spectra (CDCl3), the CH2 group appears as a singlet at 3.85–4.26 ppm (1H) and at 37.3–38.2 
ppm (13C), respectively. The characteristic absorptions of C(4)=O and C(2)=Se are observed at 
171.8–173.8 ppm and at 200.2–205.5 ppm. The CI-MS spectra (NH3) show the [M+H]+ peak as 
the base peak, in addition to an intensive [M+NH4]+ peak, and all products gave correct 
elemental analyses for C, H, N, and S. 
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Finally, the structure of 7a was established unambiguously by X-Ray crystallography (Figure 1). 
The 1,3-thiazolidine ring is almost planar, and the attached atoms Se, O(4), and C(6) deviate 
only slightly from this plane. On the other hand, the benzene ring at N(3) is twisted out of this 
plane and is oriented almost orthogonal to the plane of the heterocycle with a dihedral angle 
between these planes of 71.7(1)°). 
Analogously, the reaction of 4-methoxyphenyl isoselenocyanate (1c) with 2-mercaptopropanoic 
acid (6b) gave 2-(4-methoxyphenyl)-5-methylselenorhodanine (7f) in 74% yield. 
 
 Table 1. Synthesis of Thiazolidinones (7a-f) and Thiazinanones (8a-c) from Isoselenocyanates  
Isoselenocyanate (1) Mercapto Acid (6) Products Yield (%) [Time,h] 
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Figure 1. ORTEP plot53 of the molecular structure of 7a (arbitrary numbering of the atoms; 50% 
probability ellipsoids) 
 
Furthermore, the corresponding reactions of 1a, b, and f with 3-mercaptopropanoic acid (6c) 
afforded the 2-selenoxo-1,3-thiazinan-4-ones (8a-c), i.e., the six-membered homologues of 
selenorhodanines (Scheme 2, Table 1). In the 1H-NMR spectra of 8a-c, the two CH2 groups 
resonate at ca. 2.75 and 3.50 ppm, whereas their 13C-signals appear at ca. 33.5 and 45.0 ppm. 
The chemical shifts of C(4)=O and C(2)=Se (ca. 173 and 204 ppm, respectively) are almost 
unaffected by the ring size (cf. 7a-f). 
 
A reaction mechanism for the formation of 7 and 8 is proposed in Scheme 2. The nucleophilic 
mercapto group undergoes an addition to the isoselenocyanate (1) to give a 
(seleno)(thio)carbamate A as an intermediate. It is worth mentioning that no additional base is 
needed to catalyze the reaction. The subsequent cyclization of A' occurs almost 
instantaneously with loss of water to afford the selenorhodanines (7) in a one-pot-reaction. In 
the case of the sterically crowded isoselenocyanate (1d), a longer reaction time of 12 h is 
needed. Similarly, in the case of the reactions of 1a, b, and f with 3-mercaptopropanoic acid 
(6c), the starting material had been consumed complete only after 12 h. 
 
It is noteworthy that the ring closure of A/A’ occurs exclusively via nucleophilic attack of the N-
atom at the carboxylic group. None of the corresponding 2-imino-1,3-selenathiolanone or its 
 homologue has been detected, in contrast to the previously described formation of 2-imino-1,3-
selenazolidines and 2-imino-1,3-selenazinanes (3),43 2-arylaminoselenazolo[5,4-b]pyrid-ines,28 
1H-5-selena-1,3,6-triazaaceanthrylenes,54 and 6H-[5,1,3]benzoselenadiazocines.33 On the 
other hand, in the reaction of 2-aminobenzonitrile with phenyl isoselenocyanate, the 
intermediate selenourea derivatives undergo a cyclization by nucleophilic attack of the N-atom 
at the nitrile group, which leads to 4-phenylaminoquinazoline-2(1H)-selones.55 
 
In conclusion, the reaction of isoselenocyanates (1) with α- or β-mercaptocarboxylic acids is a 
novel, rapid and efficient synthesis of 2-selenoxo-1,3-thiazolidine-4-ones (7, selenorhodanines) 
and 2-selenoxo-1,3-thiazinan-4-ones (8). 
 
EXPERIMENTAL 
 
General remarks. TLC: silica gel 60 F254 plates (0.25 mm, Merck). Column chromatography 
(CC): silica gel 60 (0.040–0.063 mesh, Merck). Melting points: Büchi B-540 apparatus, in a 
capillary, uncorrected. 1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra: Bruker ARX-300 
instrument, in CDCl3; chemical shifts in ppm, coupling constants J in Hz. EI-MS and CI-MS: 
Finnigan SSQ-700 or MAT-90 instrument; EI mode: 70 eV; CI mode: NH3 as carrier gas. 
 
Starting materials. 2-Mercaptoacetic acid (6a), 2-mercaptopropanoic acid (6b), 3-mercapto-
propanoic acid (6c), and formanilid are commercially available (Fluka). Isoselenocyanates (1) 
were prepared according to Barton’s procedure, which starts from formamides.27 N-(4-
Chlorophenyl)-, N-(4-bromophenyl)-, N-(4-methoxyphenyl)-, N-(4-methylphenyl)-, and N-(2,6-
dimethylphenyl)formamide were prepared from the respective commercial aniline and 95% 
formic acid by using a slightly modified procedure.56 The solution was heated to reflux for 30 
min and evaporated to dryness in vacuo. The residue was dissolved in Et2O and washed with 
dilute acetic acid (5%), water, and aqueous NaHCO3 (5%). The aqueous layer was extracted 
with Et2O, the combined organic extracts were dried with MgSO4 and evaporated under 
reduced pressure. The crude products were purified by recrystallization using a mixture of EtOH 
and water. 
 
Synthesis of 2-Selenoxo-1,3-thiazolidin-4-ones (7a-f) and 2-Selenoxo-1,3-thiazinan-4-
ones (8a-c). General Procedure. A round bottom flask equipped with a condenser and a 
 magnetic stirrer was charged with an aryl isoselenocyanate (1.0 mmol) in 20 mL of a mixture of 
EtOH and water (2:1). The respective mercapto carboxylic acid was then added dropwise. The 
mixture was stirred at rt for several hours (see table) before being poured onto 50 mL of cold 
water. After 2 h of stirring, the precipitate formed was filtered and purified, if necessary, by 
recrystallization from EtOH. 
 
3-Phenyl-2-selenoxo-1,3-thiazolidin-4-one (7a). Orange plates, mp 217–219°C (EtOH). 1H-
NMR: 4.26 (s, CH2); 7.40 (d, J = 8.2, 2 arom. H); 7.59–7.67 (m, 3 arom. H). 13C-NMR: 38.2 
(CH2); 128.6 (2 arom. CH); 129.1 (3 arom. CH); 136.5 (1 arom. C); 173.8 (CO); 205.5 (CSe). CI-
MS: 275 (26, [M+NH4]+), 258 (100, [M+H]+). Anal. Calcd for C9H7NOSSe: C, 42.19; H, 2.75; N, 
5.47; S, 12.52. Found: C, 42.20; H, 2.75; N, 5.42; S, 12.40. 
 
3-(4-Methylphenyl)-2-selenoxo-1,3-thiazolidin-4-one (7b). Orange crystals, mp 201–203°C 
(EtOH). 1H-NMR: 2.42 (s, Me); 3.90 (s, CH2); 7.10, 7.35 (AA’BB’, J = 8.2, 4 arom. H). 13C-
NMR: 21.3 (Me); 37.4 (CH2); 128.0 (2 arom. CH); 130.3 (2 arom. CH); 133.2, 140.0 (2 arom. C); 
173.2 (CO); 203.3 (CSe). CI-MS: 289 (31, [M+NH4]+), 272 (100, [M+H]+). Anal. Calcd for 
C10H9NOSSe: C, 44.45; H, 3.36; N, 5.18; S, 11.87. Found: C, 44.30; H, 3.21; N, 5.03; S, 11.78. 
 
3-(4-Methoxyphenyl)-2-selenoxo-1,3-thiazolidin-4-one (7c). Orange crystals, mp 182–184°C 
(EtOH). 1H-NMR: 3.85 (s, MeO); 3.89 (s, CH2); 7.03, 7.14 (AA’BB’, J = 8.2, 4 arom. H). 13C-
NMR: 37.3 (CH2); 55.4 (MeO); 114.9 (2 arom. CH); 128.2 (1 arom. C); 129.4 (2 arom. CH); 
160.3 (1 arom. C); 173.3 (CO); 203.6 (CSe). CI-MS: 305 (32, [M+NH4]+), 288 (100, [M+H]+). 
Anal. Calcd for C10H9NO2SSe: C, 41.96; H, 3.17; N, 4.89; S, 11.20. Found: C, 42.23; H, 3.33; N, 
4.88; S, 11.12. 
 
3-(2,6-Dimethylphenyl)-2-selenoxo-1,3-thiazolidin-4-one (7d). Orange crystals, mp 123–125°C 
(EtOH). 1H-NMR: 2.10 (s, 2 Me); 3.95 (s, CH2); 7.18–7.33 (m, 3 arom. H). 13C-NMR: 117.5 (2 
Me); 37.3 (CH2); 127.5 (1 arom. CH); 127.9 (2 arom. CH); 130.0, 136.1 (2 arom. C); 173.2 (CO); 
200.2 (CSe). CI-MS: 303 (60, [M+NH4]+), 286 (100, [M+H]+). Anal. Calcd for C11H11NOSSe: C, 
46.48; H, 3.90; N, 4.93; S, 11.28. Found: C, 46.33; H, 4.12; N, 5.00; S, 11.32. 
 
3-(4-Bromophenyl)-2-selenoxo-1,3-thiazolidin-4-one (7e). Orange crystals, mp 111–113°C 
(EtOH). 1H-NMR: 3.92 (s, CH2); 7.11, 7.67 (AA’BB’, J = 8.1, 4 arom. H). 13C-NMR: 37.4 (CH2); 
 123.3 (1 arom. C); 130.0 (2 arom. CH); 132.9 (2 arom. CH); 138.5 (1 arom. C); 171.8 (CO); 
203.8 (CSe). CI-MS: 353 (35, [M+NH4]+), 336 (100, [M+H]+). Anal. Calcd for C9H6NOBrSSe: C, 
32.26; H, 1.80; N, 4.18; S, 9.57. Found: C, 32.41; H, 2.02; N, 3.98; S, 10.00. 
 
3-(4-Methoxyphenyl)-5-methyl-2-selenoxo-1,3-thiazolidin-4-one (7f). Orange crystals, mp 133–
135°C (EtOH). 1H-NMR: 1.78 (d, J = 7.3, Me); 3.81 (s, MeO); 4.11 (q, J = 7.2, CH); 6.88, 7.22 
(AA’BB’, J = 8.2, 4 arom. H). 13C-NMR: 17.5 (Me); 46.7 (CH); 55.4 (MeO); 114.7 (2 arom. CH); 
127.3 (2 arom. CH); 129.4, 159.1 (2 arom. C); 174.4 (CO); 204.2 (CSe). CI-MS: 319 (46, 
[M+NH4]+), 302 (100, [M+H]+). Anal. Calcd for C11H11NO2SSe: C, 44.00; H, 3.69; N, 4.67; S, 
10.68. Found: C, 43.79; H, 3.82; N, 4.33; S, 11.00. 
 
3-Phenyl-2-selenoxo-1,3-thiazinan-4-one (8a). Orange crystals, mp 152–154°C (EtOH). 1H-
NMR: 2.76, 3.55 (2t, J = 6.9, 2 CH2); 7.36–7.58 (m, 5 arom. H). 13C-NMR: 33.3, 45.3 (2 CH2); 
125.0 (1 arom. CH); 126.2 (2 arom. CH); 128.8 (2 arom. CH); 139.6 (1 arom. C); 172.6 (CO); 
204.2 (CSe). CI-MS: 288 (100, [M+NH4]+), 272 (54, [M+H]+). Anal. Calcd for C10H9NOSSe: C, 
44.45; H, 3.36; N, 5.18; S, 11.87. Found: C, 44.32; H, 3.12; N, 5.34; S, 12.01. 
 
3-(4-Methylphenyl)-2-selenoxo-1,3-thiazinan-4-one (8b). Orange crystals, mp 164–166°C 
(EtOH). 1H-NMR: 2.73, 3.53 (2t, J = 6.9, 2 CH2); 7.12, 7.38 (AA’BB’, J = 8.1, 4 arom. H). 13C-
NMR: 20.2 (Me); 33.6, 45.0 (2 CH2); 128.9 (2 arom. CH); 130.8 (2 arom. CH); 134.4, 139.9 (2 
arom. C); 174.0 (CO); 203.8 (CSe). CI-MS: 303 (100, [M+NH4]+), 286 (67, [M+H]+). Anal. Calcd 
for C11H11NOSSe: C, 46.48; H, 3.90; N, 4.93; S, 11.28. Found: C, 46.45; H, 4.12; N, 5.13; S, 
11.07. 
 
3-(4-Chlorophenyl)-2-selenoxo-1,3-thiazinan-4-one (8c). Orange crystals, mp 163–165°C 
(EtOH). 1H-NMR: 2.72 (t, J = 6.9, CH2); 3.45 (t, J = 7.0, CH2); 7.22, 7.38 (d, J = 8.1, 4 arom. H). 
13C-NMR: 33.1, 45.0 (2 CH2); 129.9 (2 arom. CH); 132.5 (2 arom. CH); 133.1, 138.3 (2 arom. 
C); 173.4 (CO); 204.0 (CSe). CI-MS: 323 (100, [M+NH4]+), 306 (44, [M+H]+). Anal. Calcd for 
C10H8NOClSSe: C, 39.42; H, 2.65; N, 4.60; S, 10.53. Found: C, 39.22; H, 2.85; N, 4.34; S, 
11.11. 
 
X-Ray Crystal-Structure Determination of 7a (see Table 2 and Figure 1).57 All measurements 
were performed on a Nonius KappaCCD area-detector diffractometer58 using graphite-
 monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 
cooler. The data collection and refinement parameters are given in Table 2, and a view of the 
molecule is shown in Figure 1. Data reduction was performed with HKL Denzo and Scalepack.59 
The intensities were corrected for Lorentz and polarization effects, and an absorption correction 
based on the multi-scan method60 was applied. The structure was solved by direct methods 
using SIR92,61 which revealed the positions of all non-H-atoms. All non-H-atoms were refined 
anisotropically. All of the H-atoms were placed in geometrically calculated positions and refined 
using a riding model where each atom was assigned a fixed isotropic displacement parameter 
with a value equal to 1.2Ueq of its parent atom. The refinement of the structure was carried out 
on F2 using full-matrix least-squares procedures, which minimized the function Σw(Fo2 – Fc2)2. A 
correction for secondary extinction was applied. Neutral atom scattering factors for non-H-
atoms were taken from ref.62a, and the scattering factors for H-atoms were taken from ref.63 
Anomalous dispersion effects were included in Fc;
64 the values for ƒ’ and ƒ” were those of ref.62b 
The values of the mass attenuation coefficients are those of ref.62c All calculations were 
performed using the SHELXL97 program.65 
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